Results 31 to 40 of about 13,102 (151)
Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response [PDF]
, 2011 International audienceBetter survival in combined pulmonary fibrosis and emphysema than in lone pulmonary fibrosis: bias or reality? A response to Centrilobular emphysema combined with pulmonary fibrosis results in improved survival by Todd et al ...
Vincent Cottin +5 more
core +1 more source
The Journal of Association of Chest Physicians, 2023 Combined pulmonary fibrosis and emphysema (CPFE) is a heterogenous lung disease documented in smokers, which includes emphysema in upper lobes and pulmonary fibrosis in lower lobes. CPFE in nonsmokers is rare, and very few literatures are available.
Shital Patil, Sham Toshniwal
doaj +1 more source
Pulmonary hypertension associated with chronic lung diseases
Swiss Medical Weekly, 2016 In 2015, the international guidelines for diagnosis and treatment of pulmonary hypertension were updated. Group 3 of the current classification includes pulmonary hypertension associated with chronic obstructive pulmonary disease (COPD), interstitial ...
Manuela Funke +2 more
doaj +1 more source
Pirfenidone combined with N-acetylcysteine in treatment of pulmonary fibrosis: a case report and literature review [PDF]
Xin yixue, 2022 Objective To evaluate the efficacy and safety of pirfenidone combined with N-acetylcysteine （NAC） in the treatment of pulmonary fibrosis, aiming to provide basis for clinical medication. Methods Clinical data of 1 patient with combined pulmonary fibrosis
Li Wenjuan, Zhang Liyi, Zhou Yuqi
doaj +1 more source
Kaohsiung Journal of Medical Sciences, 2017 In this study, we aimed to explore the association of genetic polymorphism in matrix metalloproteinase-9 (MMP-9) and transforming growth factor-β1 (TGF-β1) and the susceptibility to combined pulmonary fibrosis and emphysema (CPFE).
Ling Xu, Wei Bian, Xiao-Hua Gu, Ce Shen
doaj +1 more source
, 2021 Rahul Sangani,1 Andrew Ghio,2 Stacey Culp,3 Zalak Patel,4 Sunil Sharma1 1Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, West Virginia University, Morgantown, WV, USA; 2Human Studies Facility, US Environmental Protection ...
Culp S +4 more
core
Autopsy and Case Reports, 2017 In 2005, the combined pulmonary fibrosis and emphysema (CPFE) was first defined as a distinct entity, which comprised centrilobular or paraseptal emphysema in the upper pulmonary lobes, and fibrosis in the lower lobes accompanied by reduced diffused ...
André Carramenha de Góes Hirano +6 more
doaj +1 more source
Respiratory Medicine Case Reports, 2018 Myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA) is well-known as a serological marker for small-vessel vasculitis. However, when a smoker with interstitial lung disease (ILD) exhibits serum ANCA positivity without systemic vasculitis ...
Masahiro Nemoto +7 more
doaj +1 more source
A newly-defined entity: combined pulmonary fibrosis and emphysema syndrome
, 2015 Combined pulmonary fibrosis and emphysema (CPFE) syndrome is a rare disease characterized with shortness of breath, upper lobe emphysema, lower lobe fibrosis and impairment of gas exchange.
Ozcelik, Neslihan, Ozsu, Savas
core +1 more source
A Case Report of Combined Pulmonary Fibrosis and Emphysema
Amrita Journal of MedicineCombined pulmonary fibrosis and emphysema (CPFE) is an underdiagnosed condition characterized by upper lobe emphysema and lower lobe fibrosis, most often seen in male smokers.
Supriya Adiody, Vishnu Narayanan
doaj +1 more source